Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Prevention of Colorectal Adenoma Recurrence
NCT04885426Unknown
- Sponsor
- Jing-yuan Fang
- Start
- Aug 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of metformin in Colorectal Adenoma (CRA), sponsored by Jing-yuan Fang. Primary endpoint: Colorectal Adenoma Recurrence Rate at 2 years. Status: unknown.
02
Drugs
metformin
03
Conditions
Colorectal Adenoma (CRA)
Beyond the preview
Go deeper on NCT04885426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04885426.